A detailed history of Sykon Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Sykon Capital LLC holds 12,014 shares of PFE stock, worth $343,239. This represents 0.13% of its overall portfolio holdings.

Number of Shares
12,014
Previous 12,014 -0.0%
Holding current value
$343,239
Previous $333 Million 0.83%
% of portfolio
0.13%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $22,174 - $25,919
-691 Reduced 5.44%
12,014 $399 Million
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $458,904 - $530,941
12,705 New
12,705 $466 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sykon Capital LLC Portfolio

Follow Sykon Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sykon Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sykon Capital LLC with notifications on news.